[Treatment of uncomplicated duodenal ulcer with an antacid-containing attapulgite. Effectiveness and tolerance in comparison with a H2 receptor antagonist].
Mayer
R
R
Sack
W
W
Wagner
W
W
D000863:Antacids / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D017616:Magnesium Compounds; D008297:Male; D008875:Middle Aged; D012825:Silicon / Q000627:therapeutic use*; D017655:Silicon Compounds
D000863:Antacids; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D017616:Magnesium Compounds; D017655:Silicon Compounds; D008274:Magnesium; C026325:attapulgite; D012825:Silicon
Behandlung des unkomplizierten Ulcus duodeni mit einem Attapulgit-haltigen Antazidum. Wirksamkeit und Verträglichkeit im Vergleich zu einem H2-Rezeptor-Antagonisten.